FOXO4-DRI — D-retro-inverso isomer senolytic research peptide. Targeted disruption of FOXO4-p53 interaction.

FOXO4-DRI is a D-retro-inverso isomer research peptide designed to disrupt the FOXO4-p53 interaction in senescent cells. It represents one of the leading targeted senolytic research compounds.
FOXO4-DRI mimics the p53 binding region of FOXO4 in retro-inverso configuration, binding p53 and displacing it from FOXO4 — releasing p53 to trigger apoptosis selectively in senescent cells.
Used in: senolytic research, cellular senescence studies, FOXO4-p53 pathway research, comparative senolytic studies.
| Compound | FOXO4-DRI |
| Available Strengths | 10mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.